FUROSCIX Trademark

Trademark Overview

On Tuesday, July 12, 2016, a trademark application was filed for FUROSCIX with the United States Patent and Trademark Office. The USPTO has given the FUROSCIX trademark a serial number of 87101278. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, February 16, 2024. This trademark is owned by scPharmaceuticals Inc.. The FUROSCIX trademark is filed in the Pharmaceutical Products category with the following description:

Diuretics; pharmaceutical preparations for the treatment of edema, congestive heart failure, cirrhosis, and renal disease
furoscix

General Information

Serial Number87101278
Word MarkFUROSCIX
Filing DateTuesday, July 12, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, February 16, 2024
Registration Number5287573
Registration DateTuesday, September 12, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Goods and ServicesDiuretics; pharmaceutical preparations for the treatment of edema, congestive heart failure, cirrhosis, and renal disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 18, 2016
Primary Code005
First Use Anywhere DateWednesday, May 10, 2017
First Use In Commerce DateWednesday, May 10, 2017

Trademark Owner History

Party NamescPharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NamescPharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NamescPharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Friday, February 16, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, February 16, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, February 16, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 29, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, September 25, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, June 8, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 8, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 12, 2017REGISTERED-PRINCIPAL REGISTER
Friday, August 11, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, August 10, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 2, 2017SOU EXTENSION 1 GRANTED
Friday, July 21, 2017SOU EXTENSION 1 FILED
Friday, July 21, 2017USE AMENDMENT FILED
Tuesday, August 1, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 21, 2017SOU TEAS EXTENSION RECEIVED
Friday, July 21, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, February 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 10, 2016ASSIGNED TO LIE
Monday, October 24, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 24, 2016EXAMINER'S AMENDMENT ENTERED
Monday, October 24, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 24, 2016EXAMINERS AMENDMENT E-MAILED
Monday, October 24, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, October 20, 2016ASSIGNED TO EXAMINER
Monday, July 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 15, 2016NEW APPLICATION ENTERED

Related Keywords

furoscix failure cirrhosis renal disease heart congestive pharmaceutical preparations treatment edema